Boston Scientific Settles $610M Tax Dispute
Executive Summary
The giant device-maker has settled a long-running dispute over transfer pricing with the US Internal Revenue Service. Boston Scientific expects to pay almost $610m in back taxes and interest.
You may also be interested in...
Boston Scientific Plans IRS Settlement
Boston Sci plans to pay $275m to settle transfer-pricing disputes with the US Internal Revenue Service. A financial analyst views the settlement as a win for the company because it’s well below what the IRS initially sought.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.